Company: LIMN
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001104659-25-055078
Chunk: 23

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 23
---
 Discussion and Analysis of Financial Condition and Results of Operations” beginning on page 44, which information is incorporated herein by reference.

Reference is made to the disclosure
contained in the ParentCo Form 10-Q in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” beginning on page 9, which information is incorporated herein by reference.

The information set forth in Exhibit 99.6 is incorporated herein by
reference.

The information set forth
in Exhibit 99.8 is incorporated herein by reference.

Security Ownership of Certain Beneficial Owners and Management

The following table sets forth
information regarding the beneficial ownership of shares of ParentCo Common Stock, as of April 30, 2025, following the consummation
of the Business Combination, by:

| · | each of the Company’s officers and directors; and |

| · | all executive officers and directors of the Company as a group. |

Beneficial ownership is determined
according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it
possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable
or exercisable within 60 days. Shares of common stock issuable pursuant to options or warrants are deemed to be outstanding for purposes
of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding
for purposes of computing the beneficial ownership percentage of any other person.

Subject to the paragraph above,
percentage ownership of ParentCo Common Stock is based on 26,014,633 shares of ParentCo Common Stock outstanding upon consummation of
the Business Combination on April 30, 2025, after giving effect to the redemptions by Iris public stockholders in connection with
the Business Combination. The table below does not include the shares of ParentCo Common Stock underlying the ParentCo Public Warrants
or the ParentCo Private Placement Warrants because these securities are not exercisable within 60 days of April 30, 2025.

<div align='center'>14</div>

Unless otherwise indicated,
we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock owned
by them.

| Name and Address of Beneficial Owner(1)                         |     | Number of              
 Shares of Common Stock 
 Beneficially Owned     |           |     | % of         
 Outstanding  
 Common Stock |      |   |